(Q36288217)
Statements
1 reference
CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma (English)
1 reference
Takumi Kumai
1 reference
Toshihiro Nagato
1 reference
Hiroya Kobayashi
1 reference
Yuki Komabayashi
1 reference
Seigo Ueda
1 reference
Kan Kishibe
1 reference
Takayuki Ohkuri
1 reference
Miki Takahara
1 reference
Esteban Celis
1 reference
Yasuaki Harabuchi
1 reference
10 March 2015
1 reference
1 reference
697-705
1 reference
2 references
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference